Profile
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide for researching and delivering life-changing medicines, science will always remain its passion. Its clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology throughout its preclinical services. Transpharmation has a strong focus on preclinical evaluation of potential CNS therapeutics including the areas of epilepsy, pain, neurodegeneration, depression, anxiety, schizophrenia and cognition.
Website
transpharmation.comContact
-
Joseph Araujo, Chief Corporate Development OfficerTel: +1 416-677-6085
-
-
-
-
-
Event details
Date: November 3 - 5, 2025
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
22 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
BioBackers is a nascent investor intelligence platform for therapeutics companies raising capital. The platform… -
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. It… -
Bough Biosciences is a pre-seed stage biotech focused on the development of a therapy for treatment resistant… -
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target… -
iCLASS is a revolutionary TechBIO company merging multi-proteomics-centered data generation with next-generation… -
Intrepid Labs revolutionizes drug formulation with Valiant™, an AI-driven robotic lab that explores… -
JN Nova Pharma is Canadian biotech company which has worked with National Research Council of Canada… -
Noa Therapeutics is pioneering a novel biased signal approach to AhR… -
Pattern’s patented PPI-100 activates innate immunity against cancers… -
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation… -
Singularity Pharma is a drug discovery business developing novel therapeutics for… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress new medicine…